Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q04609 (
prostate-specific membrane antigen
)
1,287
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MLN
-591 is a monoclonal antibody specific for
prostate-specific membrane antigen
that is being developed by Cornell University, BZL Biologics, ImmunoGen Inc and Millennium Pharmaceuticals Inc for the potential treatment of prostate cancer.
MLN
-591 was in phase II trials by May 2002.
...
PMID:Technology evaluation: MLN-591, Cornell University/BZL Biologics/ImmunoGen/Millennium. 1259 64
